LEADERSHIP IN LATERAL FLOW TECHNOLOGY SINCE 2003
Mologic was founded in 2003 by Paul and Mark Davis and now employs approx 70 people in the UK and USA. Here are some of the milestones along the way.
It all started in the 80’s
It all started in the 80’s with Paul’s innovative work when he invented Lateral Flow technology which led to the foundation of the Clear Blue pregnancy test.
In the beginning
Mologic started with a laboratory in Bedford, UK delivering high-value contract research and innovation to local clients
Investment for growth
Mologic secured private investment which accelerated the development of our core technology and IP portfolio.
Attracting major clients
By now we had established a strong track record and attracted clients including the NHS, Inverness Medical, 3M and Church and Dwight.
Acquired by Alere
Mologic was acquired by Alere (formerly Inverness Medical) and became a dedicated R&D group with long-term targets.
We established the respiratory disease business unit and sepsis programme. We acquired Ovine antibody capability to support small molecule reagent and high-performance antibody development.
Wound Chek goes live
Our chronic wound care diagnostic product reached the market, launched as Wound Chek by Systagenix.
Mologic became an independent company again after an investor buy-in and management buy-back. We retained all the Mologic technology, personnel, facilities, capability, intellectual property and a deep product pipeline.
A dynamic product pipeline
We secured investment for product development and the delivery of an extensive product pipeline. Mologic became ISO 13485 and CMDCAS certified (including self-testing).
We established the Centre for Advanced Rapid Diagnostics (CARD) with the backing of a grant from the Bill & Melinda Gates Foundation. The centre focuses on the development of a transformational, low-cost, next-generation rapid point-of-care platform that doesn’t require a reader.
Mologic goes to Market
The first products from the Mologic portfolio achieved the CE mark and were launched commercially: BVProⓇ for women’s health and PERiPLEXⓇ for peritoneal dialysis.
Expansion into the USA
Mologic secured investment to expand into North America and established a US headquarters near Boston, MA.